Biological Activity of sym-Triazines with Acetylcholine-like Substitutions as Multitarget Modulators of Alzheimer’s Disease-Reference-Cited by-同舟云学术

Biological Activity of sym-Triazines with Acetylcholine-like Substitutions as Multitarget Modulators of Alzheimer’s Disease

Published:2013-03-21 Issue:6 Volume:4 Page:924-929
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Veloso Anthony J.¹,Chow Ari M.¹,Dhar Devjani¹,Tang Derek W. F.¹,Ganesh Hashwin V.S.¹,Mikhaylichenko Svetlana¹,Brown Ian R.¹,Kerman Kagan¹

Affiliation:

1. Department of Physical and Environmental Sciences and ‡Centre for the Neurobiology of Stress, Department of Biological Sciences, University of Toronto Scarborough, 1265 Military Trail, Toronto, ON M1C 1A4, Canada

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/cn400028w

Reference31 articles.

1. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-protein

2. Metallo-ROS in Alzheimer's Disease: Oxidation of Neurotransmitters by CuII-β-Amyloid and Neuropathology of the Disease

3. Microglia enhance β-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species

4. Solid‐State NMR Spectroscopic Investigation of Aβ Protofibrils: Implication of a β‐Sheet Remodeling upon Maturation into Terminal Amyloid Fibrils

5. A? Oligomers ? a decade of discovery

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydrophobicity modulation via the substituents at positions 2 and 4 of 1,3,5-triazine to enhance therapeutic ability against Alzheimer's disease for potent serotonin 5-HT6R agents;European Journal of Medicinal Chemistry;2023-11

2. Missing puzzle in crystal engineering: 2-pyridone and [1,3,5]-triazine-2,4-diamine, the two most common cyclic hydrogen bonding sticky sites, in a single core;CrystEngComm;2023

3. Hybrid molecules based on 1,3,5‐triazine as potential therapeutics: A focused review;Drug Development Research;2020-06-24

4. Phosphodiesterase 5 inhibitors as novel agents for the treatment of Alzheimer’s disease;Brain Research Bulletin;2019-11

5. Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents;ACS Chemical Neuroscience;2019-07-16